HK1154385A1 - Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof - Google Patents
Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereofInfo
- Publication number
- HK1154385A1 HK1154385A1 HK11108513.8A HK11108513A HK1154385A1 HK 1154385 A1 HK1154385 A1 HK 1154385A1 HK 11108513 A HK11108513 A HK 11108513A HK 1154385 A1 HK1154385 A1 HK 1154385A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- salt
- inhibitory activity
- uracil compound
- deoxyuridine triphosphatase
- novel uracil
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008146334 | 2008-06-03 | ||
| PCT/JP2009/002481 WO2009147843A1 (ja) | 2008-06-03 | 2009-06-02 | ヒトデオキシウリジントリホスファターゼ阻害活性を有する新規ウラシル化合物又はその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1154385A1 true HK1154385A1 (en) | 2012-04-20 |
Family
ID=41397926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK11108513.8A HK1154385A1 (en) | 2008-06-03 | 2011-08-15 | Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8530490B2 (xx) |
| EP (1) | EP2295414B1 (xx) |
| JP (1) | JP4688975B2 (xx) |
| KR (1) | KR101384940B1 (xx) |
| CN (1) | CN102056905B (xx) |
| AU (1) | AU2009254656B2 (xx) |
| BR (1) | BRPI0913590B1 (xx) |
| CA (1) | CA2726579C (xx) |
| CY (1) | CY1113244T1 (xx) |
| DK (1) | DK2295414T3 (xx) |
| ES (1) | ES2392220T3 (xx) |
| HK (1) | HK1154385A1 (xx) |
| HR (1) | HRP20120820T1 (xx) |
| MX (1) | MX2010013275A (xx) |
| MY (1) | MY149180A (xx) |
| PL (1) | PL2295414T3 (xx) |
| PT (1) | PT2295414E (xx) |
| RU (1) | RU2495873C2 (xx) |
| SI (1) | SI2295414T1 (xx) |
| TW (1) | TWI466871B (xx) |
| WO (1) | WO2009147843A1 (xx) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2782280C (en) * | 2009-11-30 | 2019-02-26 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor effect potentiator |
| SG10202010626PA (en) * | 2011-03-31 | 2020-11-27 | Schaefer Konstanze | Perfluorinated compounds for the non-viral transfer of nucleic acids |
| WO2014107622A1 (en) * | 2013-01-07 | 2014-07-10 | University Of Southern California | Deoxyuridine triphosphatase inhibitors |
| JP6513095B2 (ja) * | 2014-01-03 | 2019-05-15 | ユニバーシティ オブ サザン カリフォルニア | ヘテロ原子含有デオキシウリジントリホスファターゼ阻害剤 |
| EP3290038A4 (en) * | 2015-04-30 | 2018-12-26 | Taiho Pharmaceutical Co., Ltd. | Agent for alleviating adverse reaction to antitumor drug |
| CN107531646B (zh) | 2015-05-01 | 2020-11-03 | 大鹏药品工业株式会社 | 尿嘧啶化合物的结晶 |
| WO2017006271A1 (en) | 2015-07-08 | 2017-01-12 | University Of Southern California | Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage |
| EP3319939A1 (en) | 2015-07-08 | 2018-05-16 | CV6 Therapeutics (NI) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| US10544105B2 (en) | 2015-07-08 | 2020-01-28 | Cv6 Therapeutics (Ni) Limited | Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage |
| US10577321B2 (en) | 2015-07-08 | 2020-03-03 | University Of Southern California | Deoxyuridine triphosphatase inhibitors |
| AU2017205531B2 (en) | 2016-01-08 | 2021-05-13 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor agent containing immunomodulator and anti-tumor effect potentiator |
| US11168059B2 (en) | 2016-11-23 | 2021-11-09 | Cv6 Therapeutics (Ni) Limited | Amino sulfonyl compounds |
| US11174271B2 (en) | 2016-11-23 | 2021-11-16 | Cv6 Therapeutics (Ni) Limited | 6-membered uracil isosteres |
| US10829457B2 (en) | 2016-11-23 | 2020-11-10 | Cv6 Therapeutics (Ni) Limited | Nitrogen ring linked deoxyuridine triphosphatase inhibitors |
| WO2018098207A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| WO2018098206A1 (en) * | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| US11247984B2 (en) | 2017-01-05 | 2022-02-15 | Cv6 Therapeutics (Ni) Limited | Uracil containing compounds |
| AU2021297566A1 (en) | 2020-06-26 | 2023-01-19 | Cv6 Therapeutics (Ni) Limited | Combination therapy with deoxyuridine triphosphatase inhibitors |
| CN111763176A (zh) * | 2020-07-10 | 2020-10-13 | 常州制药厂有限公司 | 一种GnRH受体拮抗剂关键中间体及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4341161A1 (de) | 1993-12-02 | 1995-06-08 | Michael Prof Dr Zeppezauer | Membrangängiger Wirkstoff zur Störung der DNA-Biosynthese |
| DK0763529T3 (da) * | 1995-03-29 | 2003-11-10 | Taiho Pharmaceutical Co Ltd | Uracilderivater og antitumorvirkningspotentiator og antitumormiddel indeholdende samme |
| RU2102390C1 (ru) * | 1996-06-06 | 1998-01-20 | Научно-исследовательская лаборатория иммунохимиотерапии лепры и иммунотропных средств с клиникой и опытно-экспериментальным производством МЗМП России | N-(6-метил-2,4-диоксо-1,2,3,4-тетрагидропиримидинил-5-сульфонил) пиразин-2-карбоксамид, обладающий противолепрозной, противотуберкулезной и иммунотропной активностью, способ его получения |
| JP2002028486A (ja) * | 2000-07-14 | 2002-01-29 | Toyobo Co Ltd | アルデヒド類吸着分解剤及びその製造方法 |
| JP2002284686A (ja) * | 2001-03-28 | 2002-10-03 | Sankyo Co Ltd | スルホンアミド化合物を含有する医薬組成物 |
| AU2003218933A1 (en) | 2002-04-17 | 2003-11-03 | Affinium Pharmaceuticals, Inc. | Purified dutpase from helicobacter pylori |
| GB0219896D0 (en) | 2002-08-27 | 2002-10-02 | Bayer Ag | Dihydropyridine derivatives |
| JP4534122B2 (ja) * | 2003-12-26 | 2010-09-01 | トヨタ自動車株式会社 | ハイブリッドシステム |
| GB0400290D0 (en) * | 2004-01-08 | 2004-02-11 | Medivir Ab | dUTPase inhibitors |
| NZ573793A (en) * | 2006-07-24 | 2012-01-12 | Korea Res Inst Chem Tech | Hiv reverse transcriptase inhibitors |
| CA2782280C (en) * | 2009-11-30 | 2019-02-26 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor effect potentiator |
-
2009
- 2009-06-02 JP JP2010515773A patent/JP4688975B2/ja active Active
- 2009-06-02 WO PCT/JP2009/002481 patent/WO2009147843A1/ja active Application Filing
- 2009-06-02 US US12/996,079 patent/US8530490B2/en active Active
- 2009-06-02 MY MYPI2010005742A patent/MY149180A/en unknown
- 2009-06-02 KR KR1020107026676A patent/KR101384940B1/ko active IP Right Grant
- 2009-06-02 TW TW98118261A patent/TWI466871B/zh active
- 2009-06-02 DK DK09758110.2T patent/DK2295414T3/da active
- 2009-06-02 PL PL09758110T patent/PL2295414T3/pl unknown
- 2009-06-02 EP EP09758110A patent/EP2295414B1/en active Active
- 2009-06-02 PT PT09758110T patent/PT2295414E/pt unknown
- 2009-06-02 MX MX2010013275A patent/MX2010013275A/es active IP Right Grant
- 2009-06-02 AU AU2009254656A patent/AU2009254656B2/en active Active
- 2009-06-02 ES ES09758110T patent/ES2392220T3/es active Active
- 2009-06-02 CA CA2726579A patent/CA2726579C/en active Active
- 2009-06-02 SI SI200930396T patent/SI2295414T1/sl unknown
- 2009-06-02 RU RU2010154425/04A patent/RU2495873C2/ru active
- 2009-06-02 CN CN200980120862.5A patent/CN102056905B/zh active Active
- 2009-06-02 BR BRPI0913590-1A patent/BRPI0913590B1/pt active IP Right Grant
-
2011
- 2011-08-15 HK HK11108513.8A patent/HK1154385A1/xx unknown
-
2012
- 2012-10-11 HR HRP20120820AT patent/HRP20120820T1/hr unknown
- 2012-10-19 CY CY20121100981T patent/CY1113244T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2295414A1 (en) | 2011-03-16 |
| PL2295414T3 (pl) | 2013-02-28 |
| AU2009254656A1 (en) | 2009-12-10 |
| KR101384940B1 (ko) | 2014-04-11 |
| SI2295414T1 (sl) | 2012-12-31 |
| CA2726579A1 (en) | 2009-12-10 |
| DK2295414T3 (da) | 2012-10-22 |
| US20110082163A1 (en) | 2011-04-07 |
| CY1113244T1 (el) | 2016-04-13 |
| EP2295414A4 (en) | 2011-09-14 |
| RU2010154425A (ru) | 2012-07-20 |
| TW201000452A (en) | 2010-01-01 |
| WO2009147843A1 (ja) | 2009-12-10 |
| CA2726579C (en) | 2015-02-17 |
| TWI466871B (zh) | 2015-01-01 |
| MX2010013275A (es) | 2011-03-15 |
| JPWO2009147843A1 (ja) | 2011-10-27 |
| PT2295414E (pt) | 2012-11-30 |
| HRP20120820T1 (hr) | 2012-11-30 |
| CN102056905B (zh) | 2014-03-26 |
| ES2392220T3 (es) | 2012-12-05 |
| BRPI0913590B1 (pt) | 2021-07-06 |
| MY149180A (en) | 2013-07-31 |
| US8530490B2 (en) | 2013-09-10 |
| RU2495873C2 (ru) | 2013-10-20 |
| JP4688975B2 (ja) | 2011-05-25 |
| KR20110013427A (ko) | 2011-02-09 |
| BRPI0913590A2 (pt) | 2015-10-20 |
| AU2009254656A2 (en) | 2011-01-13 |
| EP2295414B1 (en) | 2012-09-26 |
| AU2009254656B2 (en) | 2013-07-18 |
| CN102056905A (zh) | 2011-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1154385A1 (en) | Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof | |
| EP2172453A4 (en) | COMPOUND HAVING 11 ß-HSD1 INHIBITION ACTIVITY | |
| ZA201002608B (en) | Azolecarboxamide compound or salt thereof | |
| EP1854793A4 (en) | NEW AMINOPYRIDEIN COMPOUND WITH SYK-HEMDERING EFFECT | |
| TWI340645B (en) | Solution for tissue adhesion prevention | |
| EP2065369A4 (en) | UREA CONNECTION OR SALT THEREOF | |
| EP2231624A4 (en) | TRIAZINE AND CORRESPONDING COMPOUNDS WITH ANTIVIRAL EFFECT, COMPOSITIONS AND METHOD THEREFOR | |
| EP1981585A4 (en) | HEART SUPPORT SYSTEM | |
| EP2116269A4 (en) | BLOOD CLEANING SYSTEM | |
| GB0703417D0 (en) | Electro-surgical systems | |
| IL208638A0 (en) | 2,6-diamino-pyrimidin-5-yl-carboxamides as syk or jak kinases inhibitors | |
| IL206808A0 (en) | Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity | |
| GB0714029D0 (en) | Lantibiotic-based compounds having antimicrobial activity | |
| ZA200707227B (en) | Novel aminopyridine compound with syk inhibitory activity | |
| EP2121739A4 (en) | NOVEL POLYPEPTIDE HAVING ANTITUMOR ACTIVITY | |
| IL212403A0 (en) | Carbamate compound or salt thereof | |
| IL274522A (en) | 2,6-diamino-pyrimidin-5-yl-carboxamides as inhibitors of SYK or JAK kinases | |
| SI2149561T1 (sl) | Derivat tetrahidroizokinolin-1-on ali njegova sol | |
| IL184779A0 (en) | Novel pyrimidine nucleoside compound or salt thereof | |
| EP2168947A4 (en) | NOVEL COMPOUND HAVING SECRETASE INHIBITING ACTIVITY | |
| GB0606921D0 (en) | Skin dressing | |
| EP2017279A4 (en) | NEW AMINO-PYRIDINE DERIVATIVE WITH AURORA A SELECTIVE HEMORATIVE EFFECT | |
| GB0710260D0 (en) | Otter predation defence system | |
| GB0718220D0 (en) | Activity system | |
| PL380685A1 (pl) | System mikroaktywacji skóry |